Pure and Organic CBD & and Hemp Products

Effective medicine provided by mother nature

  • Powerful relaxant

  • Strong painkiller

  • Stress reduction
  • Energy booster

Why CBD?

More and more renowned scientists worldwide publish their researches on the favorable impact of CBD on the human body. Not only does this natural compound deal with physical symptoms, but also it helps with emotional disorders. Distinctly positive results with no side effects make CBD products nothing but a phenomenal success.

This organic product helps cope with:

  • Tight muscles
  • Joint pain
  • Stress and anxiety
  • Depression
  • Sleep disorder

Range of Products

We have created a range of products so you can pick the most convenient ones depending on your needs and likes.

CBD Capsules Morning/Day/Night:

CBD Capsules

These capsules increase the energy level as you fight stress and sleep disorder. Only 1-2 capsules every day with your supplements will help you address fatigue and anxiety and improve your overall state of health.

Order Now

CBD Tincture

CBD Tincture

No more muscle tension, joints inflammation and backache with this easy-to-use dropper. Combined with coconut oil, CBD Tincture purifies the body and relieves pain. And the bottle is of such a convenient size that you can always take it with you.

Order Now

Pure CBD Freeze

Pure CBD Freeze

Even the most excruciating pain can be dealt with the help of this effective natural CBD-freeze. Once applied on the skin, this product will localize the pain without ever getting into the bloodstream.

Order Now

Pure CBD Lotion

Pure CBD Lotion

This lotion offers you multiple advantages. First, it moisturizes the skin to make elastic. And second, it takes care of the inflammation and pain. Coconut oil and Shia butter is extremely beneficial for the health and beauty of your skin.

Order Now

Cannabidiol legal in japan usa

CBD:THCA non-psychoactive 1:5



  • CBD:THCA non-psychoactive 1:5
  • Guidance on Using CBD
  • What's the Right Dose?
  • THCA (tetrahydrocannabinolic acid) is the non-psychoactive acid form of THC found in the plant when raw. THCA converts to THC when it is. Although it doesn't make people feel high like THC, CBD is causing quite a buzz among Products made from industrial hemp that contains little or no THC are of CBD:THC so you can adjust or eliminate psychoactive effects as you prefer. Understanding the cannabinoids Synergies between CBD:THC. TLC Alpha-CAT No euphoria, sedation, light-headedness, dizziness. Practically no side.

    CBD:THCA non-psychoactive 1:5

    Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences Review. State of the art and new challenges for therapeutic applications". Implications for Treating Anxiety-Related Disorders". Journal of Natural Products. US Food and Drug Administration. Retrieved 25 June Retrieved 1 November Hard Evidence at Last? Annals of Clinical Psychiatry. A Systematic Review of the Evidence". British Journal of Clinical Pharmacology.

    A Comprehensive Update of Evidence and Recommendations". American Journal of Public Health. Cannabis and Cannabinoid Research. Drug Metabolism and Disposition. Journal of Biological Chemistry. British Journal of Pharmacology. Naunyn-Schmiedeberg's Archives of Pharmacology.

    Therapeutics and Clinical Risk Management. On the nature of the Beam test". Structure elucidation of four pyrolytic products , doi: An improved synthesis of cannabidiol". Journal of Experimental Botany. Food and Drug Administration. Retrieved January 2, Trends in Pharmacological Sciences. Department of Agriculture, State of Colorado.

    Retrieved 14 September Cannabidiol is illegal and always has been". Retrieved December 10, Retrieved 14 May National Conference of State Legislatures. Retrieved 13 January Retrieved 6 November Retrieved January 3, The Farm Bill. Retrieved January 29, Retrieved December 4, Retrieved June 2, Retrieved 19 October Retrieved 1 January Retrieved 1 February Annales de Toxicologie Analytique in French.

    Swedish Medical Products Agency. Retrieved 31 July BBC News - Health. Retrieved 8 February Retrieved May 20, They were all labelled as hemp-containing, and were offered in the form of oils, cosmetics, food products, supplements, and tinctures.

    Other equipment included Biofuge Fresco Heraeus centrifuge, Mettler Toledo analytical balance and mini vortexer. The peak area ratio of the analytes to their corresponding IS vs. Quality control samples were prepared from olive oil at concentrations of 0. The samples were then sonicated for 10 minutes at room temperature and centrifuged at 11, rpm for 10 minutes. The first 2 minutes was sent to the waste.

    Nitrogen was used as the collision gas and the curtain gas. In experiment 1 negative mode , the curtain gas was The declustering potential was V, the entrance potential was The 2nd transitions In experiment 2 positive mode , the curtain gas was The de-clustering potential was V, the entrance potential was The 2nd transition Selectivity, limit of detection and quantification, linearity, precision, accuracy, recovery, matrix effect and essential stability were assessed.

    Full validation was performed using olive oil as the matrix. Partial validation for dried plant material and cream matrices were performed to evaluate accuracy, precision, recovery, and matrix effect. To test the selectivity of this method, 8 sources of matrix were analyzed for interference including sunflower oil, coconut oil, grape seed oil, almond oil, avocado oil, two brands of olive oil and a topical cream DelivraSR.

    Each matrix was extracted in triplicate and the observed peak areas at the appropriate retention times in the chromatograph were compared to the LLOQ of each analyte and internal standard.

    A calibration curve and quality control samples were included in each batch of test articles. The ratio of analyte peak area to internal standard peak area was plotted against nominal concentration.

    A total of 5 replicate dope quality control samples at each of 4 different concentrations 0. Matrix effects were measured by comparing the peak area of the blank matrix extract spiked with standards to standards of the same concentration in solvent. Extraction recovery was measured by comparing the peak area of blank matrix extract spiked with standards before extraction procedure and after extraction procedure. Chemical stability of all analytes was evaluated under sample handling and storage conditions using five replicates of each of 0.

    Benchtop stability was evaluated at room temperature in matrix-containing extraction solvent over a period of 12 hours, and peak area was compared with that of freshly prepared samples. Processed sample stability was calculated as the ratio of the peak area of second injection to first injection. Each test article was analyzed in triplicate using the validated method, accompanied by a calibration curve and quality control samples 0.

    An accurate and robust analytical method has been developed for the quantification of 4 cannabinoids relevant to the health and safety of C. A second transition was used for qualification of each analyte, and deuterated standards were used as internal standards. The isocratic LC conditions were developed to separate the target analytes from the family of congeners likely to be present in C. Formic acid was used to buffer the HPLC mobile phase to generate a single conjugate of the acids during chromatographic separation.

    The extraction procedure involved a large dilution, which was effective at extracting the analytes and diluting the matrix components sufficiently to negate matrix effects. The method is capable of analyte quantification at concentrations orders of magnitude below levels relevant for regulatory standards. The method was validated for additional dilutions in the instance of very high concentrations of the analytes in commercial products, making the range of concentrations facilitated by the method very wide.

    Full method validation was conducted according to the FDA guideline using olive oil as matrix. Partial validation experiments were performed on two additional matrices, Delivra SR cream and dried plant material. Seven of the 8 oil matrices analyzed for selectivity contained no interfering substances with any of the analytes of interest or their internal standards. One brand of sunflower oil did contain a component that interfered with the analysis of CBD using this method.

    Representative chromatograms of blank matrix A, B , the 4 cannabinoids and their internal standards spiked in blank matrix C, D , and one test article E, F can be found in Fig 1. Using this criteria, there was no carry over for the 4 analytes. The calibration curve for 4 cannabinoids were constructed using a weighted quadratic curve of the peak area ratio of the analytes to their corresponding IS vs.

    The coefficient of variance for the LLOQ 0. Table 2 describes intra- and inter-day precision and accuracy of the 4 cannabinoids in olive oil. Intra-day and inter-day precision of the 4 analytes determined at each concentration did not exceed 8. For plant material, accuracy ranges of Similarly, cream matrix accuracies of As well the coefficient of variance was below Taken together, the method in its current state functions to accurately quantify all four cannabinoids in oil-based matrices and THC and CBD in a variety of matrices, however the accuracy of CBDA and THCA-A in complex plant materials and creams incorporates an increased level of uncertainty.

    Extraction efficiencies for the acids from plant material were acceptable between Matrix effects were more pronounced for CBDA in plant materials, with an enhancing effect particularly obvious at low concentrations Table 6. The validated method was applied to 40 finished products labelled as hemp-containing and available in Canada, ordered online or purchased in-store. The test articles included a variety of oils, plant materials, and creams in the forms of cosmetics, personal care products, hemp oils marketed for cooking, massage oil, body butter, tinctures, and supplements Fig 2 and S1 Table.

    That suggested the current regulations are working to limit access to high-THC C. Most of the cosmetic products did not contain cannabinoid levels above the very low LLOQ, although they were marketed as hemp-containing.

    Secondly, the influence of pH range 5. In authentic urine samples, the initial pH ranged from 5. The glucuronide was found to be highly labile at a storage temperature of 4 degrees C and above. However, a loss in mean total THCCOOH concentration was found, which was significantly higher in deteriorated samples than in samples without signs of deterioration after 15 days of storage at 20 degrees C.

    Automated solid-phase extraction-liquid chromatography-tandem mass spectrometry analysis of nor-Delta9- tetrahydrocannabinol carboxylic acid in human urine specimens: The automated SPE procedure eliminates the human factors of specimen handling, extraction, and derivatization, thereby reducing labor costs and rework resulting from human error or technique issues.

    Additionally, method runtime is greatly reduced e. Tetrahydrocannabinols in clinical and forensic toxicology. Cannabinoids are the natural constituents of marihuana cannabis. Cannabis is administered either by smoking or orally. A single active dose of 9THC is estimated on mg. It is hydroxylated to an active metabolite, I1 -hydroxy-delta9- tetrahydro-cannabinol OH-THC , then oxidised to an inactive norcarboxy-delta9- tetrahydrocannabinol THCCOOH , which is conjugated with glucuronic acid and predominantly excreted in the urine.

    The maximum psychological effect persists for h after administration despite of very low 9THC blood concentrations. Such a low concentration of the active compound in human organism create a demand for use of sensitive analytical methods for detection and determination of 9THC and its metabolites.

    The most effective techniques for 9THC and related compounds determination in biological material are chromatographic ones gas and liquid with mass spectrometric detection and different ionization modes.

    Fatalities happen most often after intravenous injection of hashish oil. Cannabis misuse during pregnancy is associated with severe impacts on the mother and baby health, such as newborn low birth weight, growth restriction, pre-term birth, neurobehavioral and developmental deficits.

    In most of the cases, drug abuse is omitted or denied by the mothers. Thus, toxicological analyzes using maternal-fetal matrices takes place as a suitable tool to assess drug use. Inter and intra-batch coefficients of variation were Automated extraction for the analysis of nor-delta9- tetrahydrocannabinol carboxylic acid THCCOOH in urine using a six-head probe Hamilton Microlab system and gas chromatography-mass spectrometry.

    An automated extraction scheme for the analysis of 11 -nor-delta9- tetrahydrocannabinol carboxylic acid using the Hamilton Microlab , which was modified for gravity-flow solid-phase extraction, has been evaluated. The Hamilton was fitted with a six-head probe, a modular valve positioner, and a peristaltic pump. The automated method significantly increased sample throughput, improved assay consistency, and reduced the time spent performing the extraction.

    The limit of detection, limit of quantitation, and upper limit of linearity were equivalent to the manual method: Comparison of 38 patient samples, extracted by the manual and automated extraction methods, demonstrated the following correlation statistics: Carryover was Acute injection of drugs with low addictive potential delta 9 - tetrahydrocannabinol , 3,4-methylenedioxymethamphetamine, lysergic acid diamide causes a much higher c-fos expression in limbic brain areas than highly addicting drugs cocaine and morphine.

    It is regarded as a common pharmacological property responsible for the addictive potential of drugs of abuse that they are able to activate brain areas involved in the sensation of pleasure, especially the nucleus accumbens.

    To investigate the connection between addictive potential and stimulation of critical brain areas in more detail, we studied c-fos accumulation in response to various addicting drugs in direct comparison. The substances were injected into drug-naive rats, and c-fos mRNA levels were measured throughout the brain by in situ hybridization.

    In addition to the regions that responded to LSD, there was a very pronounced c-fos signal in the nucleus accumbens core and shell and in the mammillary nuclei.

    Taken together, our study revealed that the drugs with the highest addictive potential, cocaine and morphine, yielded a very low c-fos synthesis throughout the brain whereas the brain regions closely linked to pleasure especially the nucleus accumbens responded strongly to drugs with an apparently lower addictive potential THC, LSD, MDMA. Today, the main route of introduction of tetrahydrocannabinol THC , the main active substance of cannabis, into the human body is via the lungs, from smokes produced by combustion of a haschich-tobacco mixture.

    The use of a water pipe nargileh-like intensifies its fast supply to the body. THC reaches the brain easily where it stimulates CB1 receptors; their ubiquity underlies a wide variety of effects. THC disappears from extracellular spaces by dissolving in lipid rich membranes, and not by excretion from the body. This is followed by a slow release, leading to long lasting effects originating from brain areas containing a large proportion of spare receptors "reserve receptors". Far from mimicking the effects of endocannabinoids, THC caricatures and disturbs them.

    It induces both psychical and physical dependencies, but the perception of withdrawal is weak on account of its very slow elimination. Acutely, it develops anxiolytic- and antidepressant-like effects, which causes a lot of users to abuse THC, thus leading to a tolerance desensitization of CB1 receptors making anxiety and depression to reappear more intensely than originally. THC has close relationships with schizophrenia.

    It incites to tobacco, alcohol and heroine abuses. Cannabis is commonly used by humans to relieve stress. Here, we evaluate the potential of intraperitoneally i. Therapeutic issues of marijuana and THC tetrahydrocannabinol. This article summarizes current knowledge about the medicinal value of cannabis and its principal psychoactive ingredient, delta 9- tetrahydrocannabinol THC , particularly in the control of nausea and vomiting, in glaucoma, and in reduction of spasticity in multiple sclerosis.

    The major issues in the controversy about marijuana and medicine, primarily moral and ethical, are discussed. Tetrahydrocannabinol and endocannabinoids in feeding and appetite. The physiological control of appetite and satiety, in which numerous neurotransmitters and neuropeptides play a role, is extremely complex. Here we describe the involvement of endocannabinoids in these processes. These endogenous neuromodulators enhance appetite in animals.

    The same effect is observed in animals and in humans with the psychotropic plant cannabinoid Delta 9 - tetrahydrocannabinol , which is an approved appetite-enhancing drug.

    The CB 1 cannabinoid receptor antagonist SRA blocks the effects on feeding produced by the endocannabinoids. If administered to mice pups, this antagonist blocks suckling.

    In obese humans, it causes weight reduction. Very little is known about the physiological and biochemical mechanisms involved in the effects of Delta 9 - tetrahydrocannabinol and the cannabinoids in feeding and appetite.

    Inhibition of cortiocosteroidogenesis by delta tetrahydrocannabinol. ACTH, cholera toxin, cyclic AMP but not pregnenolone-induced steroidogenesis in Y-1 functional mouse adrenal tumor cells was significantly inhibited by delta tetrahydrocannabinol , cannabidiol, and cannabinol. The inhibition of steroidogenesis could not be correlated with a general depression in cell function or viability.

    The data suggest that cannabinoids inhibit corticosteroidogenesis at a site between the synthesis of cAMP and of pregnenolone. Cannabis Intoxication Case Series: The Dangers of Edibles Containing Tetrahydrocannabinol. In this case series, we describe a population of predominantly pediatric patients who were inadvertently exposed to a THC-containing product in San Francisco.

    All patients presented to hospitals with a variety of constitutional symptoms and all were discharged home within 12 hours. In general, pediatric patients had more severe symptoms and longer hospital length of stay, and, uniquely, a majority presented with leukocytosis and elevated lactic acid levels. We recommend that efforts be made to increase general public awareness in regard to the potential hazards of THC-containing edibles resembling commercially available food products.

    Published by Elsevier Inc. Kinetics and molecular modeling. Results of experiments showed pseudo-first order reaction kinetics, with an activation barrier of 85 kJ mol -1 and a pre-exponential factor of 3.

    Each of these mechanisms might play a role, depending on the actual process conditions. Formic acid proved to be a good model for a catalyst of such a reaction. Also, the computational idea of catalysis by water to catalysis by an acid , put forward by Li and Brill, and Churchev and Belbruno was extended, and a new direct keto-enol route was found.

    Evidence for this was found by performing an extraction experiment with Cannabis Flos. It revealed the presence of short chain carboxylic acids supporting this hypothesis. The effect of conditions influencing endogenous prostaglandins on the activity of delta'- tetrahydrocannabinol in mice.

    The neuroprotective actions of cannabidiol and other cannabinoids were examined in rat cortical neuron cultures exposed to toxic levels of the excitatory neurotransmitter glutamate. Cannabinoids protected equally well against neurotoxicity mediated by N-methyl-d-aspartate receptors, 2-amino 4-butylhydroxyisoxazolyl propionic acid receptors, or kainate receptors.

    The neuroprotection observed with cannabidiol and THC was unaffected by cannabinoid receptor antagonist, indicating it to be cannabinoid receptor independent. Previous studies have shown that glutamate toxicity may be prevented by antioxidants. Cannabidiol, THC and several synthetic cannabinoids all were demonstrated to be antioxidants by cyclic voltametry. Cannabidiol and THC also were shown to prevent hydroperoxide-induced oxidative damage as well as or better than other antioxidants in a chemical Fenton reaction system and neuronal cultures.

    These data also suggest that the naturally occurring, nonpsychotropic cannabinoid, cannabidiol, may be a potentially useful therapeutic agent for the treatment of oxidative neurological disorders such as cerebral ischemia. Jerry; Beardsley, Patrick M. These receptors are normally activated by endogenous lipids, including anandamide and 2-arachidonoyl glycerol 2-AG. To this end, adult male mice and rats were trained to discriminate THC 5.

    Significant decreases in responding may have prevented assessment of adequate endocannabinoid doses. In rats, neither URB nor JZL engendered significant THC-appropriate responding, but co-administration of these two enzyme inhibitors approached full substitution. The present results highlight the complex interplay between anandamide and 2-AG and suggest that endogenous increases of both endocannabinoids are most effective in elicitation of THC-like discriminative stimulus effects.

    Methamphetamine METH is a potent psychostimulant with neurotoxic properties. Heavy use increases the activation of neuronal nitric oxide synthase nNOS , production of peroxynitrites, microglia stimulation, and induces hyperthermia and anorectic effects. Most METH recreational users also consume cannabis. This final rule adopts without changes an interim final rule with request for comments published in the Federal Register on March 23, On July 1, , the U.

    Food and Drug Administration FDA approved a new drug application for Syndros, a drug product consisting of dronabinol [ - -deltatrans- tetrahydrocannabinol deltaTHC ] oral solution.

    Neither absolute THC content nor morphology allows the unequivocal discrimination of fiber cultivars and drug strains of Cannabis sativa L. Using PCR-based markers in two segregating populations, we proved that the THCA synthase gene represents the postulated B locus and that specific sequence polymorphisms are absolutely linked either to the THC-predominant or the THC-intermediate chemotype. The absolute linkage provides an excellent reliability of the marker signal in forensic casework.

    For validation, the species-specific marker system was applied to a large number of casework samples and fiber hemp cultivars. Cannabinoid ester constituents from high-potency Cannabis sativa. Eleven new cannabinoid esters, together with three known cannabinoid acids and Delta9- tetrahydrocannabinol Delta9-THC , were isolated from a high-potency variety of Cannabis sativa. The structures were determined by extensive spectroscopic analyses to be beta-fenchyl Delta9- tetrahydrocannabinolate 1 , epi-bornyl Delta9- tetrahydrocannabinolate 2 , alpha-terpenyl Delta9- tetrahydrocannabinolate 3 , 4-terpenyl Delta 9- tetrahydrocannabinolate 4 , alpha-cadinyl Delta9- tetrahydrocannabinolate 5 , gamma-eudesmyl Delta9- tetrahydrocannabinolate 6 , gamma-eudesmyl cannabigerolate 7 , 4-terpenyl cannabinolate 8 , bornyl Delta9- tetrahydrocannabinolate 9 , alpha-fenchyl Delta9- tetrahydrocannabinolate 10 , alpha-cadinyl cannabigerolate 11 , Delta9- tetrahydrocannabinol Delta9-THC , Delta9- tetrahydrocannabinolic acid A Delta9- THCA , cannabinolic acid A CBNA , and cannabigerolic acid CBGA.

    The isolated acids and the ester-containing fractions showed low affinity to the CB-1 receptor. Rapid identification of drug-type strains in Cannabis sativa using loop-mediated isothermal amplification assay. In Cannabis sativa L. Both strains are prohibited by law in many countries including Japan, whereas the drug-type strains are regulated in Canada and some European countries.

    As the two strains cannot be discriminated by morphological analysis, a simple method for identifying the drug-type strains is required for quality control in legal cultivation and forensic investigation. We have developed a novel loop-mediated isothermal amplification LAMP assay for identifying the drug-type strains of C. The assay showed high specificity for the drug-type strains and its sensitivity was the same as or higher than that of conventional polymerase chain reaction.

    We also showed the effectiveness of melting curve analysis that was conducted after the LAMP assay. The melting temperature values of the drug-type strains corresponded to those of the cloned drug-type THCA synthase gene, and were clearly different from those of the cloned fiber-type THCA synthase gene. Our rapid, sensitive, specific, and simple assay is expected to be applicable to laboratory and on-site detection. The parameters and variables affecting the extraction were investigated.

    Under optimum conditions 1 wt. The limit of detection was 0. Compared with conventional solid-liquid extraction, this new method avoids the use of volatile organic solvents, therefore is environmentally safer.

    Topical delta 9- tetrahydrocannabinol and aqueous dynamics in glaucoma. Systemic delta 9- tetrahydrocannabinol THC , administered either by smoking marihuana or as synthetic THC in soft gelatin capsules, lowers ocular tension in various glaucomas, but at the expense of significant decreases in systolic blood pressure.

    Topical THC in light mineral oil vehicles, though effective in laboratory animals, was not shown effective in 0. Light mineral oil, which has an affinity for corneal epithelium, is an optimum vehicle for administering drugs whose mechanisms of action are systemic rather than local within the eye. Further glaucoma research should therefore proceed with marihuanas containing insignificant levels of THC less than 0.

    Abstract Cannabidiol CBD , a major cannabinoid of hemp, does not bind to CB1 receptors and is therefore devoid of psychotomimetic properties.

    It has been argued that this may occur also after oral administration in humans. However, the experimental conversion of CBD to THC and delta8-THC in simulated gastric fluid SGF is a highly artificial approach that deviates significantly from physiological conditions in the stomach; therefore, SGF does not allow an extrapolation to in vivo conditions.

    In addition, the typical spectrum of side effects of THC, or of the very similar synthetic cannabinoid nabilone, as listed in the official Summary of Product Characteristics e.

    Cannabidiol CBD , a major cannabinoid of hemp, does not bind to CB1 receptors and is therefore devoid of psychotomimetic properties. Stevens; Lichtman, Aron H. A growing body of evidence implicates endogenous cannabinoids as modulators of the mesolimbic dopamine system and motivated behavior. In this study, we investigated the impact of THC and inhibitors of the endocannabinoid hydrolytic enzymes fatty acid amide hydrolase FAAH and monoacylglycerol lipase MAGL on operant responding for electrical stimulation of the medial forebrain bundle [intracranial self-stimulation ICSS ], which is known to activate the mesolimbic dopamine system.

    These drugs were also tested in assays of operant responding for food reinforcement and spontaneous locomotor activity. In contrast, the FAAH inhibitor PF Npyridinyl[[3-[[5- trifluoromethyl pyridinyl]oxy]phenyl]methyl]piperidinecarboxamide was largely without effect in these assays. The cannabinoid receptor type 1 receptor antagonist rimonabant, but not the cannabinoid receptor type 2 receptor antagonist SR, blocked the attenuating effects of THC, JZL, and SA on.

    On the pharmacological properties of Delta9- tetrahydrocannabinol THC. Cannabis is one of the first plants used as medicine, and the notion that it has potentially valuable therapeutic properties is a matter of current debate. The isolation of its main constituent, Delta9- tetrahydrocannabinol THC , and the discovery of the endocannabinoid system cannabinoid receptors CB1 and CB2 and their endogenous ligands made possible studies concerning the pharmacological activity of cannabinoids.

    This paper reviews some of the most-important findings in the field of THC pharmacology. Clinical trials, anecdotal reports, and experiments employing animal models strongly support the idea that THC and its derivatives exhibit a wide variety of therapeutic applications. However, the psychotropic effects observed in laboratory animals and the adverse reactions reported during human trials, as well as the risk of tolerance development and potential dependence, limit the application of THC in therapy.

    Nowadays, researchers focus on other therapeutic strategies by which the endocannabinoid system might be modulated to clinical advantage inhibitor or activator of endocannabinoid biosynthesis, cellular uptake, or metabolism. However, emerging evidence highlights the beneficial effects of the whole cannabis extract over those observed with single components, indicating cannabis-based medicines as new perspective to revisit the pharmacology of this plant.

    Obesity is one of the highest preventable causes of morbidity and mortality in the developed world [1]. It has been well known for a long time that exposure to cannabis produces an increase of appetite a phenomenon referred to as the 'munchies'. This phenomenon led to an exploration of the role of the endocannabinoid system in the regulation of obesity and associated metabolic syndrome. This effort subsequently led to the development of a successful therapeutic approach for obesity that consisted of blocking the cannabinoid CB1 receptors using ligands such as Rimonabant in order to produce weight loss and improve metabolic profile [2].

    Despite being efficacious, Rimonabant was associated with increased rates of depression and anxiety and therefore removed from the market. We recently discovered that the prevalence of obesity is paradoxically much lower in cannabis users as compared to non-users and that this difference is not accounted for by tobacco smoking status and is still present after adjusting for variables such as sex and age.

    Medicinal applications of delta tetrahydrocannabinol and marijuana. The use of crude marijuana for herbal medicinal applications is now being widely discussed in both the medical and lay literature.

    Ballot initiatives in California and Arizona have recently made crude marijuana accessible to patients under certain circumstances. As medicinal applications of pure forms of delta tetrahydrocannabinol THC and crude marijuana are being considered, the most promising uses of any form of THC are to counteract the nausea associated with cancer chemotherapy and to stimulate appetite.

    We evaluated the relevant research published between and on the medical applications, physical complications, and legal precedents for the use of pure THC or crude marijuana. Our review focused on the medical use of THC derivatives for nausea associated with cancer chemotherapy, glaucoma, stimulation of appetite, and spinal cord spasticity. Despite the toxicity of THC delivered in any form, evidence supports the selective use of pure THC preparations to treat nausea associated with cancer chemotherapy and to stimulate appetite.

    The evidence does not support the reclassification of crude marijuana as a prescribable medicine. Effects of delta tetrahydrocannabinol on evaluation of emotional images. There is growing evidence that drugs of abuse alter processing of emotional information in ways that could be attractive to users. In this study, we examined the effects of acute THC on evaluation of emotional images. Healthy volunteers received two doses of THC 7.

    THC significantly impaired recognition of facial fear and anger, but it only marginally impaired recognition of sadness and happiness. The drug did not consistently affect ratings of emotional scenes. THC' effects on emotional evaluation were not clearly related to its mood-altering effects. These results support our previous work, and show that THC reduces perception of facial threat.

    The potential for false-positive oral fluid cannabinoid results from passive exposure to THC-laden cannabis smoke raises concerns for this promising new monitoring technology. THCCOOH concentrations are in the picogram per milliliter range in oral fluid and pose considerable analytical challenges. After solid phase extraction, chromatography was performed on a Kinetex C18 column with a gradient of 0. Mean extraction efficiencies and matrix effects evaluated at low and high quality control QC concentrations were Analytical recoveries bias and total imprecision at low, mid, and high QCs were Delta tetrahydrocannabinol THC is the main psychoactive ingredient of cannabis, a drug which is commonly smoked This paper focuses on the pharmacokinetics of THC.

    In a cigarette containing 3. THC is quickly cleared from plasma in a multiphasic manner and is widely distributed to tissues, leading to its pharmacologic effects. Body fat is a long-term storage site. This particular pharmacokinetic behavior explains the lack of correlation between the THC blood level and clinical effects, contrary to ethanol.

    Cannabis is the main illicit drug found among vehicle drivers. Various traffic safety studies indicate that recent use of this drug at least doubles the risk of causing an accident, and that simultaneous alcohol consumption multiplies this risk by afactor of Since , synthetic cannabinoids have emerged on the illicit drug market. Their pharmacokinetics differs from that of THC, as they are metabolized into multiple derivatives, most of which are more active than THC itself.

    Effects of tetrahydrocannabinol on glucose uptake in the rat brain. The goal of this study was to assess the effect of THC on the cerebral glucose uptake in the rat brain. For data acquisition a Focus small animal PET scanner was used and Nine volumes of interest were defined, and the cerebral glucose uptake was calculated for each brain region. The effective concentration in this region was estimated 2. This glucose PET study showed that stimulation of CB1 receptors by THC affects the glucose uptake in the rat brain, whereby the effect of THC is regionally different and dependent on dose - an effect that may be of relevance in behavioural studies.

    Tetrahydrocannabinol THC impairs encoding but not retrieval of verbal information. Cannabis and agonists of the brain cannabinoid receptor CB 1 R produce acute memory impairments in humans. However, the extent to which cannabinoids impair the component processes of encoding and retrieval has not been established in humans. Healthy subjects were recruited from the community.

    Subjects received intravenous THC, in a placebo-controlled, double-blind, randomized manner at doses known to produce behavioral and subjective effects consistent with cannabis intoxication. Total immediate recall, short delayed recall, and long delayed recall were reduced in a statistically significant manner only when the RAVLT was administered to subjects while they were under the influence of THC experiment 2 and not when the RAVLT was administered prior.

    THC acutely interferes with encoding of verbal memory without interfering with retrieval. These data suggest that learning information prior to the use of cannabis or cannabinoids is not likely to disrupt recall of that information. Future studies will be necessary to determine whether THC impairs encoding of non-verbal information, to what extent THC impairs memory consolidation, and the role of other cannabinoids in the memory-impairing effects of cannabis.

    Careful consideration of the extraction method is very important for the measurement of cannabinoids in hemp seeds. Yang, Yi; Lewis, Melissa M. It is recognized that the endocannabinoid system ECS plays a crucial role in the modulation of food intake and other aspects of energy metabolism. THC treatment increased culture protein content and reduced methyl- 3 H-thymidine incorporation. The effects on methyl- 3 H-thymidine incorporation and lipolysis seem to be mediated through CB1- and CB2-dependent pathways.

    These results show that the ECS interferes with adipocyte biology and may contribute to adipose tissue AT remodeling. Although these observations point toward increased AT deposition, the stimulation of adiponectin production and inhibition of lipolysis may be in favor of improved INS sensitivity under cannabinoid influence.

    Delta 9 - tetrahydrocannabinol and ethanol: Serum dopamine beta-hydroxylase activity, a useful biochemical index of peripheral sympathetic nervous activity, was measured in rats treated with Delta 9 - tetrahydrocannabinol or ethanol or both substances. After 7 days of treatment with either substance, serum dopamine beta-hydroxylase activity decreased significantly.

    Combined treatment with both agents enhanced the effects of each given alone. In rats subjected to immobilization stress, treatment with Delta 9 - tetrahydrocannabinol appeared to potentiate the stress-induced increase in serum enzyme activity.

    Treatment with ethanol, with or without Delta 9 - tetrahydrocannabinol , effectively blocked this increase in enzyme activity. These results show that both substances have significant effects on the sympathetic nervous system which are critically influenced by environmental setting.

    Chronic - -delta9- tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats.

    Clinical and basic research studies have linked cannabinoid consumption to the onset of psychosis, specially schizophrenia. In the present study we have evaluated the effects of the natural psychoactive constituent of Cannabis - -delta9- tetrahydrocannabinol on the acute actions of the psychostimulant, D-amphetamine, on behaviour displayed by male rats on a hole-board, a proposed animal model of amphetamine-induced psychosis.

    Cannabinoid-amphetamine interactions were studied 1 30 min after acute injection of - -delta9- tetrahydrocannabinol 0. Acute cannabinoid exposure antagonized the amphetamine-induced dose-dependent increase in locomotion, exploration and the decrease in inactivity. Chronic treatment with - -delta9- tetrahydrocannabinol resulted in tolerance to this antagonistic effect on locomotion and inactivity but not on exploration, and potentiated amphetamine-induced stereotypies.

    Lastly, 24 h of withdrawal after 14 days of cannabinoid treatment resulted in sensitization to the effects of D-amphetamine on locomotion, exploration and stereotypies. Since - -delta9- tetrahydrocannabinol is a cannabinoid CB1 receptor agonist, densely present in limbic and basal ganglia circuits, and since amphetamine enhances monoaminergic inputs i. These findings may be relevant for the understanding of both cannabinoid-monoamines interactions and Cannabis-associated psychosis. Human urinary excretion profile after smoking and oral administration of sup 14 C delta 1- tetrahydrocannabinol.

    Urine was collected for five days after each administration route and analyzed for total delta 1-THC metabolites by radioactivity determination, for delta 1-THCoic acid by high-performance liquid chromatography, and for cross-reacting cannabinoids by the EMIT d. However, in the chronic users the excretion profiles of delta 1-THCoic acid and EMIT readings did not resemble the radioactive excretion due to the heavy influence from previous Cannabis use.

    The experiments, conducted with Science, , , Engineering yeasts as platform organisms for cannabinoid biosynthesis. The discovery of the human endocannabinoid system in the late s resulted in a growing number of known physiological functions of both synthetic and plant derived cannabinoids. Thus, manifold therapeutic indications of cannabinoids currently comprise a significant area of research.

    Here we reconstituted the final biosynthetic cannabinoid pathway in yeasts. The use of the soluble prenyltransferase NphB from Streptomyces sp. In addition to the desired product cannabigerolic acid , NphB catalyzes an O-prenylation leading to 2-O-geranyl olivetolic acid. We show for the first time that the bacterial prenyltransferase and the final enzyme of the cannabinoid pathway tetrahydrocannabinolic acid synthase can both be actively expressed in the yeasts Saccharomyces cerevisiae and Komagataella phaffii simultaneously.

    While enzyme activities in S. This study is an important step toward total biosynthesis of valuable cannabinoids and derivatives and demonstrates the potential for developing a sustainable and secure yeast bio-manufacturing platform. To ensure complete hydrolysis of conjugates and capture of total analyte content, urine samples were hydrolyzed by two methods in series. Extracted analytes were derivatized with BSTFA and quantified by gas chromatography—mass spectrometry with electron impact ionization.

    Standard curves were linear from 2. Extraction efficiencies were Intra- and interassay precision across the linear range of the assay ranged from 0. This method was applied to the analysis of urine specimens collected from individuals participating in controlled administration cannabis studies, and it may be a useful analytical procedure for determining recency of cannabis use in forensic toxicology applications.

    A comparison of the apoptotic effect of Delta 9 - tetrahydrocannabinol in the neonatal and adult rat cerebral cortex. The maternal use of cannabis during pregnancy results in a number of cognitive deficits in the offspring that persist into adulthood.

    The endocannabinoid system has a role to play in neurodevelopmental processes such as neurogenesis, migration and synaptogenesis. However, exposure to phytocannabinoids, such as Delta 9 - tetrahydrocannabinol , during gestation may interfere with these events to cause abnormal patterns of neuronal wiring and subsequent cognitive impairments.

    Aberrant cell death evoked by Delta 9 - tetrahydrocannabinol may also contribute to cognitive deficits and in cultured neurones Delta 9 - tetrahydrocannabinol induces apoptosis via the CB 1 cannabinoid receptor. In this study we report that Delta 9 - tetrahydrocannabinol microM activates the stress-activated protein kinase, c-jun N-terminal kinase, and the pro-apoptotic protease, caspase-3, in in vitro cerebral cortical slices obtained from the neonatal rat brain.

    The proclivity of Delta 9 - tetrahydrocannabinol to impact on these pro-apoptotic signalling molecules was not observed in in vitro cortical slices obtained from the adult rat brain. In contrast, in vivo administration of Delta 9 - tetrahydrocannabinol to adult rats was not associated with the apoptotic pathway in the cerebral cortex.

    The data provide evidence which supports the hypothesis that the neonatal rat brain is more vulnerable to the neurotoxic influence of Delta 9 - tetrahydrocannabinol , suggesting that the cognitive deficits that are observed in humans exposed to marijuana during gestation may be due, in part, to abnormal engagement of the apoptotic cascade during brain development.

    Repeated exposure to delta 9- tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat. Long-term abuse of marijuana by humans can induce profound behavioral deficits characterized by cognitive and memory impairments. In particular, deficits on tasks dependent on frontal lobe function have been reported in cannabis abusers. In the current study, we examined whether long-term exposure to delta9- tetrahydrocannabinol , the active ingredient in marijuana, altered the neurochemistry of the frontal cortex in rats.

    Two weeks administration of delta9- tetrahydrocannabinol reduced dopamine transmission in the medial prefrontal cortex, while dopamine metabolism in striatal regions was unaffected. These data are consistent with earlier findings of dopaminergic regulation of frontal cortical cognition. Thus, cognitive deficits in heavy abusers of cannabis may be subserved by drug-induced alterations in frontal cortical dopamine transmission.

    Cannabis use can both increase and reduce anxiety in humans. The neurophysiological substrates of these effects are unknown. To investigate the effects of 2 main psychoactive constituents of Cannabis sativa Delta9- tetrahydrocannabinol [Delta9-THC] and cannabidiol [CBD] on regional brain function during emotional processing.

    Subjects were studied on 3 separate occasions using an event-related functional magnetic resonance imaging paradigm while viewing faces that implicitly elicited different levels of anxiety. Each scanning session was preceded by the ingestion of either 10 mg of Delta9-THC, mg of CBD, or a placebo in a double-blind, randomized, placebo-controlled design.

    Fifteen healthy, English-native, right-handed men who had used cannabis 15 times or less in their life. Regional brain activation blood oxygenation level-dependent response , electrodermal activity skin conductance response [SCR] , and objective and subjective ratings of anxiety.

    Delta9- Tetrahydrocannabinol increased anxiety, as well as levels of intoxication, sedation, and psychotic symptoms, whereas there was a trend for a reduction in anxiety following administration of CBD. Cannabidiol attenuated the blood oxygenation level-dependent signal in the amygdala and the anterior and posterior cingulate cortex while subjects were processing intensely fearful faces, and its suppression of the amygdalar and anterior cingulate responses was correlated with the concurrent reduction in SCR fluctuations.

    Delta9- Tetrahydrocannabinol mainly modulated activation in frontal and parietal areas. Delta9- Tetrahydrocannabinol and CBD had clearly distinct effects on the neural, electrodermal, and symptomatic response to fearful faces.

    The effects of CBD on activation in limbic and paralimbic regions may contribute to its ability to.

    Guidance on Using CBD

    THC mg/mL | CBD THC-rich oil. THC allowed per millilitre of oil (but no potency limits for CBD since it's not psychoactive). THCA Drops. THCA TINCTURE WITH A TOUCH OF GINGER. CBDA:THCA non-psychoactive. +mg THCA per bottle. Ingredients: Wildcrafted Liquid. Many of the psychoactive effects of Δ9-THC are mediated by CB1 receptors, while nonpsychoactive cannabinoids, In the ambit of nonpsychoactive compounds, CBD represents the most valuable one from the 1–5,

    What's the Right Dose?



    THC mg/mL | CBD THC-rich oil. THC allowed per millilitre of oil (but no potency limits for CBD since it's not psychoactive).


    THCA Drops. THCA TINCTURE WITH A TOUCH OF GINGER. CBDA:THCA non-psychoactive. +mg THCA per bottle. Ingredients: Wildcrafted Liquid.


    Many of the psychoactive effects of Δ9-THC are mediated by CB1 receptors, while nonpsychoactive cannabinoids, In the ambit of nonpsychoactive compounds, CBD represents the most valuable one from the 1–5,


    This method was used to quantify CBD, CBDA, THC, and THCA-A in 40 (THC) and the structurally similar non-psychoactive cannabidiol (CBD). . Peak areas of blank matrices were required to be 1/5 the LLOQ at the.


    Since CBD, in contrast to THC, is not a controlled substance in the European .. In addition, CBN, though much less psychoactive than THC, express sedative . , , 3,3,6-Trimethyl-1,5-heptadienol, , , n.d.


    While THC and CBD are the most relevant cannabinoids to mammalian . Peak areas of blank matrices were required to be 1/5 the LLOQ at the analyte .. Oral anti-inflammatory activity of cannabidiol, a non-psychoactive.


    Cannabidiol (CBD) is a phytocannabinoid discovered in It is one of some identified CBD is not scheduled under any United Nations drug control treaties, and in Laboratory evidence indicated that cannabidiol may reduce THC clearance, . Non-psychoactive hemp (also commonly-termed industrial hemp).

    Add Comment